SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-236278
Filing Date
2020-08-31
Accepted
2020-08-31 16:33:58
Documents
21
Period of Report
2020-08-27
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d32449d8k.htm   iXBRL 8-K 35175
2 EX-1.1 d32449dex11.htm EX-1.1 159624
3 EX-4.1 d32449dex41.htm EX-4.1 102671
4 EX-5.1 d32449dex51.htm EX-5.1 13258
5 EX-99.1 d32449dex991.htm EX-99.1 11175
6 EX-99.2 d32449dex992.htm EX-99.2 11359
10 GRAPHIC g32449g0828131059087.jpg GRAPHIC 5125
11 GRAPHIC g32449g0828131059321.jpg GRAPHIC 3681
12 GRAPHIC g32449g0828131319470.jpg GRAPHIC 3681
13 GRAPHIC g32449g0829080456737.jpg GRAPHIC 1785
  Complete submission text file 0001193125-20-236278.txt   564911

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA onct-20200827.xsd EX-101.SCH 3073
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20200827_lab.xml EX-101.LAB 18139
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20200827_pre.xml EX-101.PRE 11410
14 EXTRACTED XBRL INSTANCE DOCUMENT d32449d8k_htm.xml XML 3414
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 201151897
SIC: 2834 Pharmaceutical Preparations